PetMed Express (FRA:PQM) ROCE % : -11.07% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is PetMed Express ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PetMed Express's annualized ROCE % for the quarter that ended in Dec. 2023 was -11.07%.

PetMed Express ROCE % Historical Data

The historical data trend for PetMed Express's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetMed Express ROCE % Chart

PetMed Express Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

38.04

23.49

21.53

19.03

5.26

PetMed Express Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-2.18	-0.69	-7.25	-1.47	-11.07

PetMed Express ROCE % Calculation

PetMed Express's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	5.652	/	( ( (163.166 - 51.073)	+	(156.424 - 53.716) )	/ 2 )
	=	5.652	/	( (112.093	+	102.708)	/ 2 )
	=	5.652	/	107.4005
	=	5.26 %

PetMed Express's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-11.276	/	( ( (149.237 - 38.131)	+	(158.962 - 66.391) )	/ 2 )
	=	-11.276	/	( ( 111.106	+	92.571 )	/ 2 )
	=	-11.276	/	101.8385
	=	-11.07 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

PetMed Express (FRA:PQM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PetMed Express ROCE % Related Terms

Thank you for viewing the detailed overview of PetMed Express's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PetMed Express (FRA:PQM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (FRA:PQM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PETS:USA PQM:Germany

Address

420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445

Website

https://www.petmeds.com

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

PetMed Express (FRA:PQM) Headlines

No Headlines